Polysaccharides and Lectins: A Natural Complementary Approach against the SARS-CoV-2 Pandemic

Infection with the novel coronavirus SARS-CoV-2, the cause of coronavirus disease (COVID-19), has emerged as a global pandemic, with a high toll on casualties, economic impact, and human lifestyle. Despite the recent approval of various vaccines against the virus, challenges remain, including the li...

Full description

Bibliographic Details
Published in:	Microbiology Research
Main Authors:	Radu Lefter, Prairna Balyan, Ioana-Miruna Balmus, Abdellah Ech-Chahad, Ahmad Ali, Alin Ciobica, Antoneta Dacia Petroaie, Gabriela Halitchi, Bogdan Novac, Catalina Ionescu, Fatima Zahra Kamal
Format:	Article
Language:	English
Published:	MDPI AG 2024-04-01
Subjects:	SARS-CoV-2 variants antiviral strategies antiviral polysaccharides antiviral lectins synergistic effect
Online Access:	https://www.mdpi.com/2036-7481/15/2/35

Similar Items

Algal and Cyanobacterial Lectins and Their Antimicrobial Properties
by: José Abel Fernández Romero, et al.
Published: (2021-12-01)

Biochemical characterization of a novel purified lectin extracted from Pleurotus ostreatus mushroom for its antiviral activity
by: Yousra A. El-Maradny, et al.
Published: (2025-07-01)

Characterization of a Novel Mannose-Binding Lectin with Antiviral Activities from Red Alga, <i>Grateloupia chiangii</i>
by: Hyun-Ju Hwang, et al.
Published: (2020-02-01)

Antiviral Cyanometabolites—A Review
by: Hanna Mazur-Marzec, et al.
Published: (2021-03-01)

<i>Urtica dioica</i> Agglutinin Prevents Rabies Virus Infection in a Muscle Explant Model
by: Xinyu Wang, et al.
Published: (2023-04-01)

Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo
by: Xue Wang, et al.
Published: (2021-05-01)

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
by: Emily L.C. Tan, et al.
Published: (2004-04-01)

An algal lectin griffithsin inhibits Hantaan virus infection in vitro and in vivo
by: Yajing Zhao, et al.
Published: (2022-12-01)

Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
by: Victória Riquena Grosche, et al.
Published: (2023-09-01)

Potential Antiviral Options against SARS-CoV-2 Infection
by: Aleksandr Ianevski, et al.
Published: (2020-06-01)

Identification and Tracking of Antiviral Drug Combinations
by: Aleksandr Ianevski, et al.
Published: (2020-10-01)

LECTIN-DEPENDENT DIVERSITY OF NATURAL KILLER POPULATIONS AND COMMUNICATIONS AGAINST TUMORS AND VIRUSES
by: M. V. Lakhtin, et al.
Published: (2019-10-01)

Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants
by: Wenbo Wang, et al.
Published: (2021-01-01)

Broad-Spectrum Antivirals Derived from Natural Products
by: Wen-Jun Tian, et al.
Published: (2023-04-01)

Antivirals blocking entry of enteroviruses and therapeutic potential
by: Mohd Ishtiaq Anasir, et al.
Published: (2021-01-01)

Medicinal Fungi with Antiviral Effect
by: Yu Zhang, et al.
Published: (2022-07-01)

Novel Synergistic Anti-Enteroviral Drug Combinations
by: Aleksandr Ianevski, et al.
Published: (2022-08-01)

Editorial: Plant products for antiviral therapeutics
by: Anirban Mandal, et al.
Published: (2022-10-01)

A Designed “Nested” Dimer of Cyanovirin-N Increases Antiviral Activity
by: Brian W. Woodrum, et al.
Published: (2016-06-01)

AntiviralDB: an expert-curated database of antiviral agents against human infectious diseases
by: Jie Huang, et al.
Published: (2025-10-01)

Progress in drug therapy for COVID-19 infection
by: LIU Fang-yuan, SU Xiu-lan
Published: (2020-10-01)

Medicinal Plants Used in Sri Lankan Traditional Medicine for Dengue Fever
by: Jayani K. Handagala, et al.
Published: (2024-04-01)

Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance
by: Yaqin Bai, et al.
Published: (2021-04-01)

Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model
by: Paulina Koszalka, et al.
Published: (2022-08-01)

Insights from a community-based survey on factors influencing acceptance and uptake of Paxlovid (nirmatrelvir and ritonavir) as a COVID-19 antiviral medication in Singapore
by: Sheng En Alexius Matthias Soh, et al.
Published: (2024-08-01)

Antivirals against the Chikungunya Virus
by: Verena Battisti, et al.
Published: (2021-07-01)

Silver Nanoparticles (AgNPs) as Potential Antiviral Agents: Synthesis, Biophysical Properties, Safety, Challenges and Future Directions─Update Review
by: Abhinav Sati, et al.
Published: (2025-04-01)

M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening
by: Hiroshi Yamada, et al.
Published: (2021-06-01)

Antiviral Effects and Mechanisms of Active Ingredients in Tea
by: Xinghai Zhang, et al.
Published: (2024-11-01)

Review on the Antiviral Organic Agents against Fish Rhabdoviruses
by: Shuang-Shuang Sun, et al.
Published: (2023-01-01)

Silver Nanoparticles: Review of Antiviral Properties, Mechanism of Action and Applications
by: Angelica Luceri, et al.
Published: (2023-02-01)

Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naÏve Patients Infected with Genotype 1b Hepatitis C Virus
by: Ye Wang, et al.
Published: (2015-01-01)

Antimicrobial Peptides as Potential Antiviral Factors in Insect Antiviral Immune Response
by: Min Feng, et al.
Published: (2020-09-01)

Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients
by: Daniele Lombardo, et al.
Published: (2023-12-01)

Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions
by: Mohammad A. I. Al-Hatamleh, et al.
Published: (2020-10-01)

Management of viral infections in immunocompromised cancer patients
by: Swiss Medical Weekly
Published: (2002-07-01)

Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C
by: K. Yu. Kokina, et al.
Published: (2021-04-01)

Novel and repurposed antiviral molecules for arbovirus infections with epidemic Potential: A systematic review
by: Jacopo Logiudice, et al.
Published: (2025-08-01)

Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office
by: Karem Aline Pegoraro, et al.
Published: (2023-11-01)

Effect of EGCG Extracted from Green Tea against Largemouth Bass Virus Infection
by: Yuan Cheng, et al.
Published: (2023-01-01)